Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1958 1
1961 1
1962 2
1963 2
1965 2
1966 1
1967 3
1968 2
1969 4
1970 1
1971 2
1972 6
1973 5
1974 1
1978 1
1979 1
1980 6
1981 6
1982 3
1983 5
1984 9
1985 10
1986 10
1987 8
1988 16
1989 15
1990 28
1991 16
1992 21
1993 35
1994 27
1995 30
1996 25
1997 34
1998 42
1999 42
2000 57
2001 46
2002 48
2003 51
2004 76
2005 93
2006 87
2007 87
2008 91
2009 84
2010 93
2011 145
2012 150
2013 155
2014 182
2015 201
2016 224
2017 243
2018 239
2019 256
2020 288
2021 306
2022 326
2023 288
2024 120

Text availability

Article attribute

Article type

Publication date

Search Results

3,915 results

Results by year

Filters applied: . Clear all
Page 1
Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study.
Tan RYC, Ong WS, Lee KH, Park S, Iqbal J, Park YH, Lee JE, Yu JH, Lin CH, Lu YS, Ono M, Ueno T, Naito Y, Onishi T, Lim GH, Tan SM, Lee HB, Koh J, Han W, Im SA, Tan VKM, Phyu N, Wong FY, Tan PH, Yap YS. Tan RYC, et al. Among authors: tan ph. J Natl Compr Canc Netw. 2024 May 14:1-9. doi: 10.6004/jnccn.2023.7121. Online ahead of print. J Natl Compr Canc Netw. 2024. PMID: 38744306
Integrated enhancer regulatory network by enhancer-promoter looping in gastric cancer.
Zhu T, Okabe A, Usui G, Fujiki R, Komiyama D, Huang KK, Seki M, Fukuyo M, Abe H, Ning M, Okada T, Minami M, Matsumoto M, Fan Q, Rahmutulla B, Hoshii T, Tan P, Morikawa T, Ushiku T, Kaneda A. Zhu T, et al. Among authors: tan p. NAR Cancer. 2024 May 8;6(2):zcae020. doi: 10.1093/narcan/zcae020. eCollection 2024 Jun. NAR Cancer. 2024. PMID: 38720882 Free PMC article.
Single shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad, durable and protective systemic and mucosal immune responses in mice.
Zhi Cheang NY, Tan KS, Tan PS, Purushotorma K, Yap WC, Tullett KM, Leong Chua BY, Ying-Yan Yeoh A, Hui Tan CQ, Qian X, Chen H, Wen Tay DJ, Caminschi I, Tan YJ, Macary PA, Tan CW, Lahoud MH, Alonso S. Zhi Cheang NY, et al. Among authors: tan ps. Mol Ther. 2024 May 6:S1525-0016(24)00304-6. doi: 10.1016/j.ymthe.2024.05.003. Online ahead of print. Mol Ther. 2024. PMID: 38715364 Free article.
Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer.
Zhang P, Chen Z, Shi S, Li Z, Ye F, Song L, Zhang Y, Yin F, Zhang X, Xu J, Cheng Y, Su W, Shi M, Fan S, Tan P, Zhong C, Lu M, Shen L. Zhang P, et al. Among authors: tan p. Cancer Immunol Immunother. 2024 May 7;73(7):119. doi: 10.1007/s00262-024-03677-7. Cancer Immunol Immunother. 2024. PMID: 38713205 Free PMC article. Clinical Trial.
3,915 results